{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01308",
      "entity_text" : "insulin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:4091",
      "entity_text" : "metformin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Both metformin and rosiglitazone as add-ons to insulin treatment improved the metabolic control significantly and lowered the insulin dose, indicating that it is important not only to give insulin, but also to improve insulin action in peripheral tissues and in the liver.",
  "reading_complete" : "2020-07-28T13:17:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T13:16:35Z",
  "trigger" : "lowered",
  "evidence" : [ "metformin and rosiglitazone as add-ons to insulin treatment improved the metabolic control significantly and lowered the insulin" ],
  "pmc_id" : "3005476",
  "score" : 0
}